AtlantiCare team members wore shirts touting “We be-lung together” under their scrubs, signifying their commitment to diagnosing and treating lung cancer and other lung illnesses early.
ATLANTIC CITY – AtlantiCare marked a milestone in caring for patients Aug. 24 when its Heart and Vascular Institute and Cancer Care Institute teams performed their 100th robotic bronchoscopy. Team members wore shirts touting “We be-lung together” under their scrubs, signifying their commitment to teamwork in diagnosing and treating lung cancer and other lung illnesses early.
AtlantiCare was the first hospital in New Jersey to use this technology to diagnose lung cancer and other lung issues at the earliest stages – when treatment is most effective.
“Using this minimally invasive technology has helped us seek, find and remove tiny lung nodules that in the past would have been too small to detect and/or hard to remove,” interventional pulmonologist Amit Borah, M.D. said.
According to the American Cancer Society, lung cancer is the second most common cancer in both men and women in the United States.
“Symptoms can mimic other illnesses,” Borah said. “People often learn they have lung cancer after an x-ray or other scan for another health issue shows a nodule on their lung. Even those who have no known risk factors can develop lung cancer. It is vitally important that individuals tell their primary or specialty care provider if they have symptoms.”
Borah said symptoms of lung cancer can include a general feeling of not being well or of extreme fatigue, cough that doesn’t go away, shortness of breath, hoarseness, chest pain, headache, and bone pain. Borah added unintended weight loss and coughing up blood are also symptoms.
For more information about AtlantiCare, call the AtlantiCare Access Center at 1-888-569-1000; visit www.atlanticare.org; or find AtlantiCare on Facebook.
